Floriva Tablet, Chewable
NDC Package 52796-174-01
Package Information
Floriva (vitamin a acetate, .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol, thiamine, riboflavin, niacinamide, pyridoxine, levomefolate glucosamine, folic acid, cyanocobalamin, biotin, zinc gluconate, cupric oxide, and sodium fluoride) tablets is a medication a combination product of vitamins and fluoride. This formulation utilizes a tablet, chewable delivery system. Marketed by Bongeo Pharmaceuticals, Inc., this product is identified by NDC 52796-174.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL 20 [iU]/1
- ASCORBIC ACID 75 mg/1
- BETA CAROTENE 1000 [iU]/1
- BIOTIN 40 ug/1
- CHOLECALCIFEROL 600 [iU]/1
- CUPRIC OXIDE 1 mg/1
- CYANOCOBALAMIN 6 ug/1
- FOLIC ACID 100 ug/1
- LEVOMEFOLATE GLUCOSAMINE 162 ug/1
- NIACINAMIDE 15 mg/1
- PYRIDOXINE 1.8 mg/1
- RIBOFLAVIN 1.5 mg/1
- SODIUM FLUORIDE .5 mg/1
- THIAMINE 1.3 mg/1
- VITAMIN A ACETATE 1000 [iU]/1
- ZINC GLUCONATE 5 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 52796 - Bongeo Pharmaceuticals, Inc.
- 52796-174 - Floriva
- 52796-174-01 - 1 BLISTER PACK in 1 CARTON / 1 TABLET, CHEWABLE in 1 BLISTER PACK
- 52796-174 - Floriva
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (52796-174). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52796-174-01 identifies a specific commercial package of 1 blister pack in 1 carton / 1 tablet, chewable in 1 blister pack of Floriva, a human prescription drug labeled by Bongeo Pharmaceuticals, Inc.. This tablet, chewable is formulated for oral use and contains .alpha.-tocopherol; ascorbic acid; beta carotene; biotin; cholecalciferol; cupric oxide; cyanocobalamin; folic acid; levomefolate glucosamine; niacinamide; pyridoxine; riboflavin; sodium fluoride; thiamine; vitamin a acetate; zinc gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bongeo Pharmaceuticals, Inc. on October 15, 2014. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a combination product of vitamins and fluoride. It is used in children to treat or prevent deficiency due to poor diet or low levels of fluoride in drinking water and other sources. Vitamins are important building blocks of the body and help keep you in good health. Fluoride is used to prevent dental cavities.
How is this Bongeo Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52796017401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.